Manama, October 7 (BNA) The Chief Executive Officer of Primary Health Care Centers, Dr. Jalila Al-Sayed Jawad, expressed her sincere thanks and gratitude to His Royal Highness Prince Salman bin Hamad Al Khalifa, Crown Prince and Prime Minister for his assumption of the presidency of the Council of Ministers. Guidelines for the provision of Crizanlizumab-tmca to patients with sickle cell anemia.
The new drug is the first treatment discovered twenty years ago for sickle cell patients. His Highness the Crown Prince and the Prime Minister ordered its inclusion in the treatment protocol for patients with sickle cell anemia in the Kingdom of Bahrain after completing the necessary clinical trials.
Dr. Jalila Al-Sayed Jawad praised the support provided by His Majesty King Hamad bin Isa Al Khalifa to the health sector. She also praised the order of His Royal Highness, the Crown Prince and the Prime Minister, which reflects the Kingdom’s keenness to provide comprehensive and high-quality health care for all social components. She also commended the successful leadership of His Royal Highness, the Crown Prince and Prime Minister of the national efforts during the outbreak of the Corona virus pandemic, which proved to the world the Kingdom’s determination to excel at all levels thanks to the royal patronage.
AOQ